Minaprine
| Clinical data | |
|---|---|
| Trade names | Brantur, Cantor, Isopulsan, Nortimic |
| Other names | AGR-620; AGR620; AGR-1240; AGR1240; CB-30038; CB30038 |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Drug class | Monoamine oxidase inhibitor (MAOI); Reversible inhibitor of MAO-A (RIMA) |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 2-2.5 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.043.012 |
| Chemical and physical data | |
| Formula | C17H22N4O |
| Molar mass | 298.390 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Minaprine (INN, USAN, BAN), sold under the brand name Cantor among others, is a monoamine oxidase inhibitor antidepressant drug that was used in France for the treatment of depression until it was withdrawn from the market in 1996 because it caused convulsions.